SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about press release

21 Jan 2019 Evaluate

Sanofi India has informed about a copy of press release titled ‘Combiflam ICYHOT takes on strong pain in its new ad campaign created by Ogilvy, contents of which are self-explanatory.’

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3151.70 -24.75 (-0.78%)
11-Jun-2026 13:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1801.20
Dr. Reddys Lab 1278.50
Cipla 1385.15
Zydus Lifesciences 1101.80
Lupin 2274.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: